Guardant Health GH United States — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Guardant Health in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Guardant Health's united states — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Guardant Health's united states — revenue?
- Guardant Health (GH) reported united states — revenue of $284.63M in Q1 2026.
- How has Guardant Health's united states — revenue changed year-over-year?
- Guardant Health's united states — revenue increased by 47.0% year-over-year, from $193.61M to $284.63M.
- What is the long-term trend for Guardant Health's united states — revenue?
- Over 4 years (2021 to 2025), Guardant Health's united states — revenue has grown at a 27.2% compound annual growth rate (CAGR), from $352.56M to $923.28M.
- What does united states — revenue mean?
- This metric represents the total gross sales generated from products and services provided to customers located within the United States. It captures the primary market performance for the company's diagnostic testing portfolio, including liquid biopsy and molecular residual disease tests. This figure reflects the company's ability to penetrate the domestic healthcare market and scale its clinical adoption.